Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-19-058938
Date:2019-12-02
Issuer: ACORDA THERAPEUTICS INC (ACOR)
Original Submission Date:

Reporting Person:

SABELLA LAUREN M
420 SAW MILL RIVER ROAD
ARDSLEY, NY 10502

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-12-02 S 1,513 d $1.60 12,624 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 sales pursuant to a 10b5-1 plan. these sales are primarily intended to cover the tax liability resulting from restricted stock vesting.
f2 the price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $1.53 to $1.68 per share. the reporting person will provide to the issuer, any security holder of the issuer or the sec staff, upon request, information regarding the number of shares sold at each price within the range.
WhaleWisdom Logo

Elevate your investments